What precautions should people with cystic fibrosis take during illness such as flu or colds? 

Respiratory viruses such as the common cold and influenza pose a significant risk to individuals with cystic fibrosis because they can lead to a rapid increase in mucus production and inflammation. These illnesses often serve as a trigger for more serious bacterial infections, which can result in a lasting decline in lung function. In the United Kingdom, management strategies focus on early intervention and the intensification of daily treatments to prevent a viral illness from becoming a severe pulmonary exacerbation. By following a structured plan developed with a specialist multidisciplinary team, patients can better manage these seasonal threats and protect their long-term respiratory health. 

What We’ll Discuss in This Article 

• The importance of early communication with your specialist cystic fibrosis centre. 

• Adjusting airway clearance and physiotherapy routines during illness. 

• The role of antiviral medications and “rescue packs” of antibiotics. 

• Nutritional and hydration strategies to support the immune system. 

• Managing medication interactions, particularly with CFTR modulators. 

• Essential infection control measures within the household. 

Immediate contact and medical consultation 

The first and most critical precaution is to contact your specialist cystic fibrosis centre as soon as you experience the onset of viral symptoms such as a sore throat, runny nose, or fever. The NHS recommends that individuals with cystic fibrosis seek medical advice early to determine if antiviral treatments or a change in their antibiotic regimen is necessary. Early consultation allows the clinical team to assess whether the symptoms are purely viral or if a bacterial “tune-up” is required. In many cases, the team may request a sputum sample to check for any new bacteria that may have taken advantage of the weakened immune system. 

Intensifying airway clearance and physiotherapy 

During a cold or flu, the body produces significantly more mucus, which is often thicker and harder to clear than usual. To manage this, patients are typically advised to increase the frequency of their airway clearance sessions. Instead of the usual twice-daily routine, your physiotherapist may recommend three or four sessions a day until the symptoms subside. NICE clinical standards emphasize that maintaining clear airways is the primary defence against the secondary bacterial infections that often follow a viral illness. Using nebulised mucolytics, such as hypertonic saline, before these sessions can help to loosen the extra secretions and make them easier to cough up. 

Use of antiviral medications and rescue packs 

For those eligible, antiviral medications for the flu are most effective when started within 48 hours of the first symptoms. These drugs do not cure the flu but can significantly reduce the severity and duration of the illness, lowering the risk of complications like pneumonia. Many patients in the UK are also provided with a “rescue pack” of oral antibiotics to keep at home. These are started immediately at the first sign of a change in mucus colour or an increase in cough, as pre-arranged with the specialist team. This proactive approach ensures that bacterial growth is suppressed before it can cause structural damage to the lungs. 

Managing nutrition and hydration 

Maintaining a high caloric intake is essential when the body is fighting an infection, as the metabolic demand increases significantly during illness. Even if your appetite is low, it is important to continue taking your pancreatic enzymes with any food or nutritional supplements. High-energy drinks or frequent small snacks can help maintain weight and provide the energy needed for increased physiotherapy. Staying well-hydrated is also a vital precaution, as fluids help to keep the mucus in the lungs and sinuses thinner and less sticky. If you have cystic-fibrosis-related diabetes, you may need to monitor your blood sugar more frequently, as illness can cause glucose levels to rise. 

Monitoring for medication interactions 

As of 2026, many patients are now taking highly effective CFTR modulator therapies like Kaftrio or Alyftrek. While these medications should generally be continued during a cold or flu, certain antiviral treatments can interact with them. For example, if you are prescribed certain COVID-19 or flu treatments, your specialist team may need to adjust your modulator dose for a short period. It is essential to never stop or change your modulator dose without explicit instructions from your cystic fibrosis centre. Your pharmacist within the multidisciplinary team will be able to check for any potential “drug-drug” interactions to ensure your treatment remains both safe and effective. 

Household infection control measures 

To prevent the spread of the virus to other family members and to avoid catching additional germs, strict hygiene must be maintained within the home. NHS guidance suggests that people with cystic fibrosis should avoid close contact with others who are visibly unwell and should practice frequent handwashing with soap and water. If possible, sleeping in a separate room and using separate towels or drinking glasses can reduce the viral load in the household. It is also recommended that all household members stay up to date with their own flu and COVID-19 vaccinations to create a “cocoon” of protection around the person with cystic fibrosis. 

Conclusion 

Taking proactive precautions during a flu or cold is essential for anyone living with cystic fibrosis to prevent a viral illness from leading to permanent lung damage. By intensifying airway clearance, starting prescribed antivirals or antibiotics early, and maintaining high standards of nutrition and hygiene, patients can navigate the winter months more safely. The cornerstone of a successful recovery is clear and immediate communication with your specialist multidisciplinary team. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides educational guidance on managing viral illnesses with cystic fibrosis, strictly following the 2026 clinical standards of the NHS and NICE. The content has been reviewed by Dr. Rebecca Fernandez, a UK-trained physician with experience in internal medicine, cardiology, and emergency care. Our goal is to provide safe, factual, and actionable information to help patients and caregivers manage the risks associated with seasonal respiratory infections within the United Kingdom.